Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 170

1.

High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change.

Pokharel Y, Mouhanna F, Schneider ALC, Rawlings AM, Knopman DS, Nambi V, Virani SS, Hoogeveen RC, Alonso A, Heiss G, Coresh J, Mosley T, Gottesman R, Selvin E, Ballantyne C, Power MC.

J Am Geriatr Soc. 2019 Jul 30. doi: 10.1111/jgs.16092. [Epub ahead of print]

PMID:
31359423
2.

Seven Metrics That Will Determine Your Cardiovascular Success or Failure.

Ballantyne CM, Nambi V.

JACC Heart Fail. 2019 Aug;7(8):648-650. doi: 10.1016/j.jchf.2019.04.008. Epub 2019 Jul 10. No abstract available.

PMID:
31302041
3.

Trends in Blood Pressure and High-Sensitivity Cardiac Troponin-T with Cardiovascular Disease: The Cardiovascular Health Study.

Tehrani DM, Fan W, Nambi V, Gardin J, Hirsch CH, Amsterdam E, deFilippi CR, Polonsky T, Wong ND.

Am J Hypertens. 2019 Jun 21. pii: hpz102. doi: 10.1093/ajh/hpz102. [Epub ahead of print]

PMID:
31232455
4.

Understanding by General Providers of the Echocardiogram Report.

Trang A, Kampangkaew J, Fernandes R, Tiwana J, Misra A, Hamzeh I, Blaustein A, Aguilar D, Shah T, Ballantyne C, Quinones M, Nagueh SF, Dokanish H, Virani SS, Deswal A, Kirkpatrick JN, Nambi V.

Am J Cardiol. 2019 Jul 15;124(2):296-302. doi: 10.1016/j.amjcard.2019.04.022. Epub 2019 Apr 24.

PMID:
31104774
5.

Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System.

Jia X, Al Rifai M, Ramsey DJ, Ahmed ST, Akeroyd JM, Nambi V, Ballantyne CM, Petersen LA, Stone NJ, Virani SS.

Am J Med. 2019 May 17. pii: S0002-9343(19)30332-8. doi: 10.1016/j.amjmed.2019.04.002. [Epub ahead of print]

PMID:
31103643
6.

Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people.

Jaspers NEM, Blaha MJ, Matsushita K, van der Schouw YT, Wareham NJ, Khaw KT, Geisel MH, Lehmann N, Erbel R, Jöckel KH, van der Graaf Y, Verschuren WMM, Boer JMA, Nambi V, Visseren FLJ, Dorresteijn JAN.

Eur Heart J. 2019 May 18. pii: ehz239. doi: 10.1093/eurheartj/ehz239. [Epub ahead of print]

PMID:
31102402
7.

Metabolomic Pattern Predicts Incident Coronary Heart Disease.

Wang Z, Zhu C, Nambi V, Morrison AC, Folsom AR, Ballantyne CM, Boerwinkle E, Yu B.

Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1475-1482. doi: 10.1161/ATVBAHA.118.312236. Epub 2019 May 16.

PMID:
31092011
8.

ApoB, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive change.

Pokharel Y, Mouhanna F, Nambi V, Virani SS, Hoogeveen R, Alonso A, Heiss G, Coresh J, Mosley T, Gottesman RF, Ballantyne CM, Power MC.

Neurology. 2019 May 28;92(22):e2580-e2593. doi: 10.1212/WNL.0000000000007574. Epub 2019 May 1.

PMID:
31043469
9.

High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.

Jia X, Sun W, Hoogeveen RC, Nambi V, Matsushita K, Folsom AR, Heiss G, Couper DJ, Solomon SD, Boerwinkle E, Shah A, Selvin E, de Lemos JA, Ballantyne CM.

Circulation. 2019 Jun 4;139(23):2642-2653. doi: 10.1161/CIRCULATIONAHA.118.038772. Epub 2019 Apr 29.

PMID:
31030544
10.

Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial.

Jia X, Akeroyd JM, Nasir K, Nambi V, Ballantyne CM, Petersen LA, Virani SS.

Circulation. 2019 Mar 5;139(10):1341-1343. doi: 10.1161/CIRCULATIONAHA.118.038691. No abstract available.

PMID:
30865483
11.

Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study.

Saeed A, Sun W, Agarwala A, Virani SS, Nambi V, Coresh J, Selvin E, Boerwinkle E, Jones PH, Ballantyne CM, Hoogeveen RC.

Atherosclerosis. 2019 Mar;282:52-56. doi: 10.1016/j.atherosclerosis.2018.12.022. Epub 2018 Dec 30.

PMID:
30685442
12.

Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial.

Virani SS, Akeroyd JM, Nambi V, Michos ED, Morris PB, Nasir K, Smith SC Jr, Stone NJ, Petersen LA, Ballantyne CM.

Circulation. 2019 Jan 15;139(3):410-412. doi: 10.1161/CIRCULATIONAHA.118.034993. No abstract available.

PMID:
30586689
13.

Is RCT (Reverse Cholesterol Transport) Ready for an RCT (Randomized Controlled Trial)?

Nambi V, Rohatgi A, Bhatt DL.

J Am Coll Cardiol. 2018 Dec 25;72(25):3270-3273. doi: 10.1016/j.jacc.2018.10.034. No abstract available.

PMID:
30573029
14.

Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponse.

Saeed A, Virani SS, Jones PH, Ballantyne CM, Nambi V.

J Clin Lipidol. 2018 Sep - Oct;12(5):1141-1145. doi: 10.1016/j.jacl.2018.05.017. Epub 2018 Jun 1.

PMID:
30318064
15.

Are All Benefits and Harms Equal?

Saeed A, Virani SS, Ballantyne CM, Taylor AA, Nambi V.

J Am Coll Cardiol. 2018 Aug 14;72(7):819-820. doi: 10.1016/j.jacc.2018.05.055. No abstract available.

16.

Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease.

Saeed A, Feofanova EV, Yu B, Sun W, Virani SS, Nambi V, Coresh J, Guild CS, Boerwinkle E, Ballantyne CM, Hoogeveen RC.

J Am Coll Cardiol. 2018 Jul 10;72(2):156-169. doi: 10.1016/j.jacc.2018.04.050.

17.

Correction to: Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions.

Saeed A, Dabhadkar K, Virani SS, Jones PH, Ballantyne CM, Nambi V.

Curr Atheroscler Rep. 2018 Jun 19;20(9):42. doi: 10.1007/s11883-018-0743-9.

PMID:
29915890
18.

Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry.

Basra SS, Wang TY, Simon DN, Chiswell K, Virani SS, Alam M, Nambi V, Denktas AE, Deswal A, Bozkurt B, Ballantyne CM, Peterson ED, Jneid H.

J Am Heart Assoc. 2018 Jun 9;7(12). pii: e008125. doi: 10.1161/JAHA.117.008125.

19.

Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions.

Saeed A, Dabhadkar K, Virani SS, Jones PH, Ballantyne CM, Nambi V.

Curr Atheroscler Rep. 2018 May 21;20(7):35. doi: 10.1007/s11883-018-0735-9. Review. Erratum in: Curr Atheroscler Rep. 2018 Jun 19;20(9):42.

PMID:
29781057
20.

Prevention of Cardiovascular Disease in Women.

Saeed A, Kampangkaew J, Nambi V.

Methodist Debakey Cardiovasc J. 2017 Oct-Dec;13(4):185-192. doi: 10.14797/mdcj-13-4-185. Review.

Supplemental Content

Loading ...
Support Center